000 | 01600 a2200409 4500 | ||
---|---|---|---|
005 | 20250517003403.0 | ||
264 | 0 | _c20151022 | |
008 | 201510s 0 0 eng d | ||
022 | _a1433-7339 | ||
024 | 7 |
_a10.1007/s00520-014-2521-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWatkins, Karen R | |
245 | 0 | 0 |
_aTolerability of denosumab in metastatic solid tumor patients with renal insufficiency. _h[electronic resource] |
260 |
_bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _cJun 2015 |
||
300 |
_a1657-62 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
650 | 0 | 4 |
_aBone Density Conservation Agents _xadverse effects |
650 | 0 | 4 |
_aBone Neoplasms _xsecondary |
650 | 0 | 4 | _aDenosumab |
650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypocalcemia _xchemically induced |
650 | 0 | 4 |
_aHypophosphatemia _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms, Second Primary _xtherapy |
650 | 0 | 4 |
_aRenal Insufficiency _xcomplications |
650 | 0 | 4 | _aRetrospective Studies |
700 | 1 | _aRogers, Jane E | |
700 | 1 | _aAtkinson, Bradley | |
773 | 0 |
_tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _gvol. 23 _gno. 6 _gp. 1657-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00520-014-2521-8 _zAvailable from publisher's website |
999 |
_c24377081 _d24377081 |